MA55756A - Mirikizumab destiné à être utilisé dans un procédé de traitement de la maladie de crohn - Google Patents

Mirikizumab destiné à être utilisé dans un procédé de traitement de la maladie de crohn

Info

Publication number
MA55756A
MA55756A MA055756A MA55756A MA55756A MA 55756 A MA55756 A MA 55756A MA 055756 A MA055756 A MA 055756A MA 55756 A MA55756 A MA 55756A MA 55756 A MA55756 A MA 55756A
Authority
MA
Morocco
Prior art keywords
mirikizumab
disease
treating crohn
crohn
treating
Prior art date
Application number
MA055756A
Other languages
English (en)
French (fr)
Inventor
Stuart William Friedrich
Paul Frederick Pollack
Jay Lawrence Tuttle
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MA55756A publication Critical patent/MA55756A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
MA055756A 2019-04-22 2020-04-15 Mirikizumab destiné à être utilisé dans un procédé de traitement de la maladie de crohn MA55756A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962836910P 2019-04-22 2019-04-22

Publications (1)

Publication Number Publication Date
MA55756A true MA55756A (fr) 2022-03-02

Family

ID=70554215

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055756A MA55756A (fr) 2019-04-22 2020-04-15 Mirikizumab destiné à être utilisé dans un procédé de traitement de la maladie de crohn

Country Status (21)

Country Link
US (1) US20220040299A1 (enExample)
EP (3) EP3958897B1 (enExample)
JP (3) JP7297930B2 (enExample)
KR (2) KR20250153865A (enExample)
CN (2) CN119700968A (enExample)
AU (2) AU2020263238C1 (enExample)
BR (1) BR112021018930A2 (enExample)
DK (1) DK3958897T3 (enExample)
EA (1) EA202192532A1 (enExample)
ES (1) ES3075314T3 (enExample)
FI (1) FI3958897T3 (enExample)
IL (2) IL286818B2 (enExample)
LT (1) LT3958897T (enExample)
MA (1) MA55756A (enExample)
MX (1) MX2021012848A (enExample)
PT (1) PT3958897T (enExample)
SG (1) SG11202110619XA (enExample)
TW (2) TWI850365B (enExample)
UA (1) UA128657C2 (enExample)
WO (1) WO2020219314A1 (enExample)
ZA (1) ZA202108094B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI850365B (zh) * 2019-04-22 2024-08-01 美商美國禮來大藥廠 治療克隆氏症(crohn's disease)的方法
KR20220066831A (ko) 2020-11-16 2022-05-24 엔브이에이치코리아(주) 습기경화형 접착제를 이용한 헤드라이닝 제조방법 및 이에 의해 제조되는 헤드라이닝

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20140049B1 (ar) 2013-03-08 2021-08-17 Lilly Co Eli أجسام مضادة ترتبط بـ il-23
US20160031983A1 (en) 2013-03-15 2016-02-04 Amgen Inc. Methods for treating crohn's disease using an anti-il23 antibody
TWI811716B (zh) * 2015-09-18 2023-08-11 德商百靈佳殷格翰國際股份有限公司 治療發炎性疾病之方法
WO2018035330A1 (en) * 2016-08-19 2018-02-22 Janssen Biotech, Inc. Methods of treating crohn's disease with an anti-nkg2d antibody
EP3652539A4 (en) * 2017-07-10 2021-03-31 Rambam Med-Tech Ltd. ASSAYS FOR EVALUATING NEUTRALIZING ANTIBODIES IN ORGANIC MEDICINE TREATED PATIENTS AND USES THEREOF IN PERSONALIZED MEDICINE
TWI850365B (zh) * 2019-04-22 2024-08-01 美商美國禮來大藥廠 治療克隆氏症(crohn's disease)的方法

Also Published As

Publication number Publication date
CN113677366A (zh) 2021-11-19
BR112021018930A2 (pt) 2022-01-18
EP3958897A1 (en) 2022-03-02
JP7761614B2 (ja) 2025-10-28
ZA202108094B (en) 2025-05-28
TW202515610A (zh) 2025-04-16
AU2020263238B2 (en) 2023-08-17
AU2020263238C1 (en) 2024-02-22
WO2020219314A1 (en) 2020-10-29
EP4778573A2 (en) 2026-07-22
TWI850365B (zh) 2024-08-01
CN119700968A (zh) 2025-03-28
EP3958897B1 (en) 2026-05-06
PT3958897T (pt) 2026-07-17
KR20250153865A (ko) 2025-10-27
AU2020263238A1 (en) 2021-11-04
SG11202110619XA (en) 2021-11-29
IL286818A (en) 2021-10-31
EA202192532A1 (ru) 2022-01-21
JP2025148449A (ja) 2025-10-07
EP4789714A2 (en) 2026-08-12
UA128657C2 (uk) 2024-09-18
KR102869852B1 (ko) 2025-10-14
NZ781127A (en) 2025-06-27
MX2021012848A (es) 2021-12-10
DK3958897T3 (da) 2026-07-20
JP7297930B2 (ja) 2023-06-26
US20220040299A1 (en) 2022-02-10
TW202103734A (zh) 2021-02-01
LT3958897T (lt) 2026-08-10
AU2023265759A1 (en) 2023-12-07
JP2023116680A (ja) 2023-08-22
ES3075314T3 (en) 2026-08-03
FI3958897T3 (fi) 2026-07-16
IL286818B1 (en) 2025-11-01
KR20210142704A (ko) 2021-11-25
IL286818B2 (en) 2026-03-01
JP2022530397A (ja) 2022-06-29
CA3134587A1 (en) 2020-10-29
IL324048A (en) 2025-12-01

Similar Documents

Publication Publication Date Title
EP3886037A4 (en) IMAGE PROCESSING DEVICE AND METHOD FOR STYLE TRANSFORMATION
EP3906043A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY'S DISEASE
EP3982261A4 (en) METHOD AND APPARATUS FOR I/O PROCESSING
EP3975106A4 (en) IMAGE PROCESSING METHOD AND APPARATUS
EP3599760A4 (en) IMAGE PROCESSING METHOD AND DEVICE
EP4021500A4 (en) METHOD FOR TREATING THYROID EYE DISEASE
EP3572050A4 (en) EXCREMENTAL TREATMENT FOR USE IN COLOSTOMIES
EP4060603A4 (en) IMAGE PROCESSING METHOD AND IMAGE DEVICE
EP3857506A4 (en) IMAGE PROCESSING DEVICE AND IMAGE PROCESSING METHOD THEREOF
EP3704668A4 (en) IMAGE PROCESSING METHOD AND DEVICE
EP3972477A4 (en) SYSTEMS AND METHODS FOR OCT-GUIDED TREATMENT OF A PATIENT
EP4030680A4 (en) APPLICATION PROCESSING PROCESS AND RELATED PRODUCT
EP3971818A4 (en) IMAGE PROCESSING METHOD AND APPARATUS
EP3716875A4 (en) DEVICE AND METHOD FOR TREATMENT OF A PROSTATE DISEASE
EP3532640A4 (en) METHOD AND SYSTEM FOR PREDICTING THE RESPONSE OF A PATIENT TO ANTIDEPRESSION TREATMENT
EP4122488A4 (en) METHODS AND MEDICATIONS FOR TREATMENT OF ALZHEIMER'S DISEASE
EP3742958A4 (en) METHOD AND DEVICE FOR TREATMENT OF EYE DISEASES
MA54928A (fr) Inhibiteur de kinase atr bay1895344 destiné à être utilisé dans le traitement d'une maladie hyper-proliférative
EP4068794A4 (en) Image processing method and apparatus
EP4122481A4 (en) METHODS AND MEDICATIONS FOR TREATMENT OF HUNTINGTON'S DISEASE
EP3777686A4 (en) DEVICE FOR PROCESSING MEDICAL IMAGES, METHOD FOR PROCESSING MEDICAL IMAGES AND PROGRAM
EP4052662A4 (en) MULTIPLE PROCESSING DEVICE FOR ENDOSCOPE AND USE THEREOF
EP3704465A4 (en) DECISION SUPPORT SYSTEM AND METHOD FOR WATER TREATMENT
EP4122490A4 (en) METHODS AND MEDICATIONS FOR TREATMENT OF PARKINSON'S DISEASE
EP3856168A4 (en) COMPOSITION AND USE FOR THE TREATMENT OF PARKINSON'S DISEASE AND RELATED DISEASES